High plasma soluble CD163 during infancy is a marker for neurocognitive outcomes in early-treated HIV-infected children
Journal of Acquired Immune Deficiency Syndromes | Apr 14, 2019
Risk factors for low CD4+ count recovery despite viral suppression among participants initiating antiretroviral treatment with CD4+ counts > 500 cells/mm3: Findings from the Strategic Timing of AntiRetroviral Therapy (START) trial
Journal of Acquired Immune Deficiency Syndromes | Apr 13, 2019
Liver enzyme elevation in pregnant women receiving antiretroviral therapy in the ANRS-French perinatal cohort
Journal of Acquired Immune Deficiency Syndromes | Apr 13, 2019
Most read this week